Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome

Journal of Clinical Oncology

Volumn 14, Issue 10, 1996, Pages 2812-2817

  Buhrer C ^a   Hartmann, R ^a   Fengler, R ^a   Rath, B ^a   Schrappe, M ^a   Janka Schaub, G ^a   Henze, G ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; IFOSFAMIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TIOGUANINE; VINCRISTINE; VINDESINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CHILD; CLINICAL TRIAL; FEMALE; HUMAN; LYMPHOBLAST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SKULL IRRADIATION; TREATMENT OUTCOME;

EID: 0029781907     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.10.2812     Document Type: Article

References (31)

1. Hammond D, Sather H, Nesbit M, et al: Analysis of prognostic factors in acute lymphoblastic leukemia. Med Pediatr Oncol 14:124-134, 1986
2. Pui CH, Crist WM: High risk lymphoblastic leukemia in children: Prognostic factors and management. Blood Rev 1:25-33, 1987
3. Schorin MA, Blattner S, Gelber RD, et al: Treatment of childhood acute lymphoblastic leukemia: Results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium protocol 85-01. J Clin Oncol 12:740-747, 1994
4. Langermann HJ, Henze G, Wulf M, et al: Estimation of tumor cell mass in childhood acute lymphoblastic leukemia: Prognostic significance and practical application. Klin Pädiatr 194:209-213, 1982
5. Buchanan GR, Rivera GK, Boyett JM, et al: Reinduction therapy in 297 children with acute lymphoblastic leukemia in first bone marrow relapse: A Pediatric Oncology Group study. Blood 72: 1286-1292, 1988
6. Pui CH, Bowman WP, Ochs J, Dodge RK, Rivera GK: Cyclic combination chemotherapy for acute lymphoblastic leukemia recurring after elective cessation of therapy. Med Pediatr Oncol 16:21-26, 1988
7. Henze G, Fengler R, Hartmann R, et al: Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM Group. Blood 78:1166-1172, 1991
8. Bührer C, Hartmann R, Fengler R, et al: Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia. Med Pediatr Oncol 21:470-476, 1993
9. Sadowitz PD, Smith SD, Shuster J, et al: Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study. Blood 81:602-609, 1993
10. Bührer C, Hartmann R, Fengler R, et al: Importance of effective central nervous system therapy in isolated bone marrow relapse of childhood acute lymphoblastic leukemia. Blood 83:3468-3472, 1994
11. Pinkel D: Curing children of leukemia. Cancer 59:1683-1691, 1987
12. Miller DR: Childhood acute lymphoblastic leukemia: 1. Biological features and their use in predicting outcome of treatment. Am J Pediatr Hematol Oncol 10:163-173, 1988
13. Champlin R, Gale RP: Acute lymphoblastic leukemia: recent advances in biology and treatment. Blood 73:2051-2066, 1989
14. Miniero R, Saracco P, Pastore G, et al: Relapse after first cessation of therapy in childhood acute lymphoblastic leukemia: A 10-year follow-up study. Med Pediatr Oncol 24:71-76, 1995
15. Rivera GK, Raimondi SC, Hancock ML, et al: Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. Lancet 337:61-66, 1991
16. Reiter A, Schrappe M, Ludwig WD, et al: Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 84:3122-3133, 1994
17. Chessells JM, Bailey C, Richards SM: Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Lancet 345:143-148, 1995
18. Rivera GK, Buchanan G, Boyett JM, et al: Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse: A Pediatric Oncology Group study. N Engl J Med 315:273-278, 1986
19. Dopfer R, Henze G, Bender-Götze C, et al: Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: Results of the German cooperative study. Blood 78:2780-2784, 1991
20. Armitage JO: Bone marrow transplantation. N Engl J Med 330:827-838, 1994
21. Uderzo C, Valsecchi MG, Bacigalupo A, et al: Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: Ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association. J Clin Oncol 13:352-358, 1995
22. Casper J, Camitta B, Truitt R, et al: Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. Blood 85:2354-2363, 1995
23. Balduzzi A, Gooley T, Anasetti C, et al: Unrelated donor marrow transplantation in children. Blood 86:3247-3256, 1995
24. Barren AJ, Horowitz MM, Pollock BH, et al: Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. N Engl J Med 331:1253-1258, 1994
25. Butturini A, Rivera GK, Bortin MM, Gale RP: Which treatment for childhood acute lymphoblastic leukemia in second remission? Lancet 1:429-432, 1987
26. Borgmann A, Schmid H, Hartmann R, et al: Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: A matched-pair analysis. Lancet 346:873-876, 1995
27. Uckun FM, Kersey JH, Haake R, et al: Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia. N Engl J Med 329:1296-1301, 1993
28. Haumann TJ, van Wering ER, van der Does-van den Berg A, et al: Value of routine bone marrow examination for detection of bone marrow relapse in children with standard risk acute lymphoblastic leukemia. Pediatr Hematol Oncol 9:41-47, 1992
29. Kumar L: Can molecular monitoring improve outcome in leukaemia? Lancet 344:348-349, 1994
30. Campana D, Pui CH: Detection of minimal residual disease in acute leukemia: methodological advances and clinical significance. Blood 85:1416-1434, 1995
31. Rogers PC, Bleyer WA, Coccia P, et al: Yield of unpredicted bone marrow relapse diagnosed by routine marrow aspiration in children with acute lymphoblastic leukemia. Lancet 1:1320-1322, 1989